-
THE ANALYTICAL FRAMEWORK OF CLINICAL TRIALS EVALUATING CLINICAL OUTCOMES OF ARTIFICIAL INTELLIGENCE-BASED DIGITAL HEALTH INTERVENTIONS FOR MENTAL HEALTH DISORDERS: A SYSTEMATIC LITERATURE REVIEW
Mar 18, 2026, 21:38 PM -
COMPARING OUTCOME MODELING STRATEGIES FOR ZERO-INFLATED ABSENTEEISM IN REAL-WORLD DATA: IMPLICATIONS FOR INFERENCE ON ANXIETY SEVERITY
Mar 18, 2026, 21:38 PM -
CLINICAL AND ECONOMIC IMPACT ASSESSMENT OF HORMONAL IUD USE IN REDUCING UNPLANNED PREGNANCIES IN BRAZIL: REAL-WORLD ANALYSIS FROM A BRAZILIAN HEALTH INSURANCE COMPANY
Mar 18, 2026, 21:38 PM -
POST-2020 REAL-WORLD EVIDENCE ON PHARMACOTHERAPIES FOR CHRONIC LYMPHOCYTIC LEUKEMIA: A SCOPING REVIEW
Mar 18, 2026, 21:38 PM -
ASSESSING THE CONCORDANCE BETWEEN SELF-REPORTED NICOTINE PRODUCT USE AND EMR DIAGNOSIS CODES IN THE ALL OF US RESEARCH PROGRAM
Mar 18, 2026, 21:38 PM -
HOSPITALIZATION COSTS ASSOCIATED WITH 30-DAY UNPLANNED READMISSIONS AND POTENTIALLY PREVENTABLE READMISSIONS IN US OLDER PATIENTS WITH ALZHEIMER’S DISEASE AND RELATED DEMENTIAS
Mar 18, 2026, 21:38 PM -
STRATEGIC MARKET ACCESS PLANNING IN BREAST AND LUNG CANCER ENABLED BYREAL-TIMEAI-ASSISTEDLIVINGSYSTEMATICLITERATUREREVIEW (REAL-SLR)SYSTEM
Mar 18, 2026, 21:38 PM -
EXPLORING THE POTENTIAL IMPACT OF THE INFLATION REDUCTION ACT’S PART D REDESIGN ON FORMULARY COVERAGE?IN COMPETITIVE CLASSES: 2024-2026
Mar 18, 2026, 21:38 PM -
A NEXT-GENERATION FRAMEWORK FOR AI-AUGMENTED, SUBMISSION-GRADE LITERATURE REVIEWS: A MULTI-PROJECT ANALYSIS OF SPEED, ACCURACY, AND WORKFLOW EVOLUTION
Mar 18, 2026, 21:38 PM -
A STRUCTURED FRAMEWORK FOR CATEGORISING UNMET NEED IN HTA: APPLICATION TO SOLID TUMOR ASSESSMENTS ACROSS EIGHT OECD COUNTRIES
Mar 18, 2026, 21:38 PM -
DESCRIPTION OF THE CHARACTERISTICS AND BURDEN OF NEUROFIBROMATOSIS TYPE 1 WITH PLEXIFORM NEUROFIBROMA IN A SAMPLE OF ADULT PATIENTS IN THE USA: RESULTS FROM A REAL-WORLD SURVEY
Mar 18, 2026, 21:38 PM -
PERFORMANCE OF AI METHODS FOR TITLE/ABSTRACT SCREENING: COMPARING CRITERIA-BASED AND ADVANCEMENT PROBABILITY-BASED SCREENING APPROACHES
Mar 18, 2026, 21:38 PM -
ARTIFICIAL INTELLIGENCE-DRIVEN CLINICAL DRUG REPORT GENERATION
Mar 18, 2026, 21:38 PM -
REAL-WORLD EVIDENCE TO SUPPORT HEALTH TECHNOLOGY ASSESSMENT AND PAYER DECISION MAKING: A REVIEW OF POLICY AND GUIDANCE ACROSS EUROPE, CANADA, AND THE UNITED STATES
Mar 18, 2026, 21:38 PM -
SUCCESSFUL USES OF REAL-WORLD EVIDENCE IN FDA LABEL UPDATES: A DESCRIPTIVE ANALYSIS OF REGULATORY TRENDS
Mar 18, 2026, 21:38 PM -
ECONOMIC IMPACT OF EARLY PREGNANCY IDENTIFICATION AND VIRTUAL GAP CLOSURE ON HEDIS METRICS
Mar 18, 2026, 21:38 PM -
DRIVERS OF MOBILE PATIENT PORTAL APP USE: INSIGHTS FOR IMPLEMENTATION AND VALUE-BASED DECISION-MAKING
Mar 18, 2026, 21:38 PM -
COMPARING HEALTH, HEALTH AND WELLBEING (HWB), AND QUALITY OF LIFE (QOL) VISUAL ANALOGUE SCALE (VAS) CONSTRUCTS WITH THE EQ-HWB-9 IN THE UNITED STATES (US), UNITED KINGDOM (UK), AND GERMANY
Mar 18, 2026, 21:38 PM -
BONE MARROW BIOPSIES IN HEMATOLOGIC CANCERS: A SYSTEMATIC REVIEW OF PATIENT AND CAREGIVER BURDEN
Mar 18, 2026, 21:38 PM -
EVALUATING THE COST-EFFECTIVENESS OF PHARMACOGENETIC TESTING VIA THE MANTARA® PGX DNA TEST: INSIGHTS FROM NHS HEALTH CHECK INTEGRATION AND UK-BASED ECONOMIC MODELLING
Mar 18, 2026, 21:38 PM
